Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Low-Dose ATG-F Reduces Non-Relapse Mortality after Reduced-Intensity Bone Marrow Transplantation from an Unrelated Donor: A Single-Center Analysis of 65 Patients.

Shigeo Fuji, Takahiro Fukuda, Sung-Won Kim, Eiji Usui, Saiko Kurosawa, Hiroki Yokoyama, Bungo Saito, Toshihiro Takahashi, Shin-ichiro Mori, Yuji Heike, Kensei Tobinai, Ryuji Tanosaki, Yoichi Takaue

Blood (2007) 110 (11): 5070.

https://doi.org/10.1182/blood.V110.11.5070.5070

Published: 2007

Journal Articles

Allogeneic Hematopoietic Cell Transplantation for the Treatment of Hematologic Malignancies Not in Remission: The Anti-Tumor Effect of Reduced-Intensity Conditioning Is Comparable to That of Conventional Myeloablative Conditioning.

Dai Maruyama, MD, Takahiro Fukuda, MD, Ruri Kato, MD, Satoshi Yamasaki, MD, Eiji Usui, MD, Yuriko Morita, MD, Sung-Won Kim, MD, Shin-ichiro Mori, MD, Ryuji Tanosaki, MD, Kinuko Tajima, PhD, Yuji Heike, MD, Atsushi Makimoto, MD, Kensei Tobinai, MD, Yoichi Takaue, MD

Blood (2005) 106 (11): 1142.

https://doi.org/10.1182/blood.V106.11.1142.1142

Published: 2005

Journal Articles

Graft-Versus-Tumor Effects after Allogeneic Hematopoietic Cell Transplantation for the Treatment of Hematologic Malignancies.

Eiji Usui, MD, Takahiro Fukuda, MD, Ruri Kato, MD, Satoshi Yamasaki, MD, Dai Maruyama, MD, Yuriko Morita, MD, Sung-Won Kim, MD, Shin-ichiro Mori, MD, Ryuji Tanosaki, MD, Kinuko Tajima, PhD, Yuji Heike, MD, Atsushi Makimoto, MD, Kensei Tobinai, MD, Yoichi Takaue, MD

Blood (2005) 106 (11): 2015.

https://doi.org/10.1182/blood.V106.11.2015.2015

Published: 2005

Journal Articles

Hematopoietic Cell Transplantation-Specific Comorbidity Index To Predict Non-Relapse Mortality and Survival after Allografting.

Ruri Kato, MD, Takahiro Fukuda, MD, Eiji Usui, MD, Satoshi Yamasaki, MD, Dai Maruyama, MD, Yuriko Morita, MD, Sung-Won Kim, MD, Shin-ichiro Mori, MD, Ryuji Tanosaki, MD, Kinuko Tajima, PhD, Yuji Heike, MD, Atsushi Makimoto, MD, Kensei Tobinai, MD, Yoichi Takaue, MD

Blood (2005) 106 (11): 2731.

https://doi.org/10.1182/blood.V106.11.2731.2731

Published: 2005

Journal Articles

Reprogramming of human postmitotic neutrophils into macrophages by growth factors

Hiroto Araki, Naoyuki Katayama, Yoshihiro Yamashita, Hiroyuki Mano, Atsushi Fujieda, Eiji Usui, Hidetsugu Mitani, Kohshi Ohishi, Kazuhiro Nishii, Masahiro Masuya, Nobuyuki Minami, Tsutomu Nobori, Hiroshi Shiku

Blood (2004) 103 (8): 2973–2980.

https://doi.org/10.1182/blood-2003-08-2742

Published: 2004

NARROW

Low-Dose ATG-F Reduces Non-Relapse Mortality after Reduced-Intensity Bone Marrow Transplantation from an Unrelated Donor: A Single-Center Analysis of 65 Patients.

Allogeneic Hematopoietic Cell Transplantation for the Treatment of Hematologic Malignancies Not in Remission: The Anti-Tumor Effect of Reduced-Intensity Conditioning Is Comparable to That of Conventional Myeloablative Conditioning.

Graft-Versus-Tumor Effects after Allogeneic Hematopoietic Cell Transplantation for the Treatment of Hematologic Malignancies.

Hematopoietic Cell Transplantation-Specific Comorbidity Index To Predict Non-Relapse Mortality and Survival after Allografting.

Reprogramming of human postmitotic neutrophils into macrophages by growth factors

Email alerts

ASH Publications

American Society of Hematology

Low-Dose ATG-F Reduces Non-Relapse Mortality after Reduced-Intensity Bone Marrow Transplantation from an Unrelated Donor: A Single-Center Analysis of 65 Patients.

Allogeneic Hematopoietic Cell Transplantation for the Treatment of Hematologic Malignancies Not in Remission: The Anti-Tumor Effect of Reduced-Intensity Conditioning Is Comparable to That of Conventional Myeloablative Conditioning.

Graft-Versus-Tumor Effects after Allogeneic Hematopoietic Cell Transplantation for the Treatment of Hematologic Malignancies.

Hematopoietic Cell Transplantation-Specific Comorbidity Index To Predict Non-Relapse Mortality and Survival after Allografting.

Reprogramming of human postmitotic neutrophils into macrophages by growth factors

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only